RSS Feeds
Search

Press releases

Press releases

Displaying 1..4 of 4 - per page
Order by
Foamix to Present at the Upcoming American Academy of Dermatology Meeting, February 18-22, 2005
Foamix is partnering with leading phamaceutical companies in developing their drugs in foam formulations. The company will present at the upcoming American Academy of Dermatology meeting in New Orleans on February 18-22, 2005 More
AMARIN REPORTS INITIATION OF ENROLLMENT AND FIRST PATIENT DOSING IN PIVOTAL PHASE III CLINICAL TRIALS FOR MIRAXION IN HUNTINGTON'S DISEASE
AMARIN REPORTS INITIATION OF ENROLLMENT AND FIRST PATIENT DOSING IN PIVOTAL PHASE III CLINICAL TRIALS FOR MIRAXION IN HUNTINGTON'S DISEASE More
AMARIN ANNOUNCES SIGNIFICANT NEUROPROTECTIVE EFFECTS OF MIRAXION
Amarin announces results from pre-clinical research conducted at Trinity College, Dublin More
AMARIN CORPORATION ANNOUNCES RESULTS OF GENE VARIANT DATA ANALYSIS FROM INITIAL MIRAXION™ PHASE III CLINICAL TRIAL
Analysis identifies characteristics of Huntington's disease patients responsive to Miraxion™ More
Displaying 1..4 of 4 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
The National Institute of Allergy and Infectious Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management
Oct 2009 - 17 pages - $500
Infectious Diseases Pipeline Databook - November 2011
Nov 2011 - 7 pages - $3,835
American Leprosy Missions - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
Deals and alliances in infectious diseases
Jun 2006 - 1458 pages - $2,495
Point of Care Diagnostics for Emerging Infectious Disease Threats (Market Analysis and Technical Considerations)
Oct 2011 - 150 pages - $3,500
The National Institute of Diabetes and Digestive and Kidney Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
National Institute of Arthritis and Musculoskeletal and Skin Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Leprosy Global Clinical Trials Review, Q1, 2011
Feb 2011 - 31 pages - $1,000
The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Mar 2011 - 32 pages - $250
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us